SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-059912
Filing Date
2014-08-12
Accepted
2014-08-12 16:16:16
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-13954_110q.htm 10-Q 897399
2 EX-31.1 a14-13954_1ex31d1.htm EX-31.1 13335
3 EX-31.2 a14-13954_1ex31d2.htm EX-31.2 11232
4 EX-32.1 a14-13954_1ex32d1.htm EX-32.1 7530
5 EX-32.2 a14-13954_1ex32d2.htm EX-32.2 7549
  Complete submission text file 0001104659-14-059912.txt   6057648

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20140630.xml EX-101.INS 823067
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20140630.xsd EX-101.SCH 56623
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20140630_cal.xml EX-101.CAL 54716
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20140630_def.xml EX-101.DEF 200058
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20140630_lab.xml EX-101.LAB 665875
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20140630_pre.xml EX-101.PRE 411001
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 141034141
SIC: 2834 Pharmaceutical Preparations